2020年12月31日星期四

Year in Review in 7 Charts: When Super-Technologies Collide

You're receiving this email as part of your subscription to Trend Trader Daily. Unsubscribe here.

Less Than 14 Hours Left! When the ball drops in NYC at midnight tonight, this amazing offer ends. Click here to learn how I'm planning to grow my wealth in 2021... and to learn how you could join me.

Year in Review in 7 Charts: When Super-Technologies Collide

By Lou Basenese
Thursday, December 31, 2020

We're saving some of the best charts for last!

You'll recall, each day this week, I'm selecting a chart to highlight a key investment trend from 2020 — a trend that promises to keep delivering profits in the New Year.

So far, we've covered semiconductors, e-commerce, small- and micro-cap stocks, air travel and mergers and acquisitions.

And today, we'll be focusing on one of the most exciting and rapidly accelerating trends in the world…

The Doctor is Now Connected

In September, I shared that DARPA, the high-tech research arm of the U.S. Department of Defense, is tipping us off to the next big tech trend, and the next big investment opportunity:

Artificial intelligence (AI).

You'll recall, DARPA committed $2 billion to accelerate the development of AI technologies. And such a massive influx of funding is igniting fresh innovation throughout the industry.

The thing is, to earn the biggest profits, we should be focusing on a specific niche of AI: healthcare.

After all, as I've shared here repeatedly: being a successful trend trader is all about identifying a burgeoning trend before it's obvious to the rest of Wall Street and Main Street.

And when it comes to AI healthcare funding, Wall Street and Main Street are still in the dark. But they won't be for long…

As data from CB Insights reveals, the "smart money" keeps pouring more and more capital into AI healthcare startups.

In fact, in Q3, funding levels in the sector hit a record level.



Thank Covid for it. Seriously!

When the government partnered with AI research institutions to mine scientific data to better understand the virus — and when biotech and pharma companies levered AI to expedite vaccine discovery — it put AI in healthcare on the map.

For good reason, too. AI can help make everything in healthcare faster, cheaper, and better. From drug discovery to medical device development to testing to patient monitoring. The list goes on and on.

I've already shared my favorite way to play this trend with subscribers to my premium research service, Micro-Cap Advantage. And now, in addition to getting access to this research, you can learn where I'm putting my own personal money starting in January.

If you're interested, check out the opportunity here. But don't delay. This expires at midnight tonight.

And by the way — if you find this opportunity isn't right for you at the moment, don't sweat it. In 2021, I'll be sharing more AI healthcare investment ideas right here in this newsletter.

Ahead of the tape,
Lou Basenese
Lou Basenese



RISK NOTICE: All investing comes with risk. That includes the investments teased in this letter. You should never invest more than you can afford to lose. Please use this research for the purpose that it's intended — as research only. You should consult a professional financial advisor before ever taking a position in any securities you see herein.

SECURITY HOLDING NOTICE: Although we are never compensated from any companies for coverage, you should be aware that Trend Trader Daily, its authors, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. While authors might actively transact in the securities mentioned, they will always have a net position that is consistent with the position set forth in our research reports, letters and updates.

DISCLAIMERS: The work included in this communication is based on diverse sources including SEC filings, current events, interviews, corporate press releases, and information published on funding platforms, but the views we express and the conclusions we reach are our own. As such, this content may contain errors, and any investments described in this content should be made only after reviewing the filings and/or financial statements of the company, and only after consulting with your investment advisor. Actual results may differ significantly from the results described herein.

Furthermore, nothing published by Trend Trader Daily, Inc should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice.

Trend Trader Daily is an independent provider of education, information and research on publicly traded companies, and as such, it accepts no direct or indirect compensation from any companies or third parties mentioned in any of our letters, reports or updates.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

没有评论:

发表评论